Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Carl Schecter will serve on our board of directors upon completion of this offering. Mr. Schecter has led his family office since 2015, overseeing a diversified portfolio of equity strategies. He has served on the advisory board of Parkside Scientific, a privately held biotechnology company using epigenomics to develop therapies for cancer and inflammatory diseases, since 2018. From 1980 to 2015, Mr. Schecter spent 35 years on Wall Street as a risk arbitrage and event-driven portfolio manager at firms including Schecter Capital (2012-2014), Diamondback Securities (2007-2012), Nomura Securities International (1998-2007), and NatWest Bank (1994-1997). From 1983 to 1994, Mr. Schecter served as
This record is keyed to SEC CIK 0002102594 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 2 institutional-holder rows on these vehicles, under 2 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.